Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
RepliCel Life Sciences Inc (REPCF)
OTHER OTC:REPCF
RepliCel Life Sciences (REPCF) Stock Price & Analysis
22 Followers
REPCF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.03 - $0.19
Previous Close$0.04
Volume550.00
Average Volume (3M)8.45K
Market Cap
$2.59M
Enterprise Value$2.60M
Total Cash (Recent Filing)C$32.48K
Total Debt (Recent Filing)C$40.96K
Price to Earnings (P/E)8.8
Beta1.12
Next Earnings
Apr 30, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding65,001,560
10 Day Avg. Volume0
30 Day Avg. Volume8,445
Standard Deviation0.22
R-Squared0.04
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-0.54
Price to Sales (P/S)7.87
Price to Cash Flow (P/CF)N/A
P/FCF Ratio2.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
RepliCel Life Sciences News
PremiumCompany Announcements
RepliCel Secures Million Dollar CEO-Backed Loan
PremiumCompany Announcements
RepliCel Proposes Asset Sale to Secure Future RoyaltiesOwnership Overview
68.70%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
31.30% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
REPCF FAQ
What was RepliCel Life Sciences Inc’s price range in the past 12 months?
RepliCel Life Sciences Inc lowest stock price was $0.03 and its highest was $0.19 in the past 12 months.
What is RepliCel Life Sciences Inc’s market cap?
Currently, no data Available
When is RepliCel Life Sciences Inc’s upcoming earnings report date?
RepliCel Life Sciences Inc’s upcoming earnings report date is Apr 30, 2024 which is in 11 days.
How were RepliCel Life Sciences Inc’s earnings last quarter?
Currently, no data Available
Is RepliCel Life Sciences Inc overvalued?
According to Wall Street analysts RepliCel Life Sciences Inc’s price is currently Overvalued.
Does RepliCel Life Sciences Inc pay dividends?
RepliCel Life Sciences Inc does not currently pay dividends.
What is RepliCel Life Sciences Inc’s EPS estimate?
RepliCel Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RepliCel Life Sciences Inc have?
RepliCel Life Sciences Inc has 65,001,560 shares outstanding.
What happened to RepliCel Life Sciences Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of RepliCel Life Sciences Inc?
Currently, no hedge funds are holding shares in REPCF
---
RepliCel Life Sciences Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
RepliCel Life Sciences Inc
RepliCel Life Sciences, Inc. operates as a regenerative medicine company. The company focuses on developing autologous cell therapies that address conditions linked to a deficit of healthy cells required for normal healing and function. Its products includes RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin, and pattern baldness. The company was founded on April 24, 1967 and is headquartered in Vancouver, Canada.
---
Technical Analysis
---